Bolder BioTechnology
is headquartered in Boulder, Colorado. Bolder BioTechnology has a revenue of $28.3M, and 105 employees. Bolder BioTechnology's main competitors are Trusted Tablets, High Times and Ubiquiti. Bolder BioTechnology has 4 followers on Owler.Bolder BioTechnology
is headquartered in Boulder, Colorado. Bolder BioTechnology has a revenue of $28.3M, and 105 employees. Bolder BioTechnology's main competitors are Trusted Tablets, High Times and Ubiquiti. Bolder BioTechnology has 4 followers on Owler.
CEO
Add
News
Nov 18, 2024
PR Newswire
Press Release: Bolder BioTechnology : NIAID Exercises Option to Continue Preclinical Development of Bolder BioTechnology's BBT-059 IL-11 Analog to Treat Acute Radiation Syndrome
Aug 26, 2020
InnovationNews
Bolder BioTechnology: Bolder BioTechnology announces positive preclinical data for BBT-032 to inhibit growth of the SARS-CoV-2 virus
Jul 23, 2019
InnovationNews
Bolder BioTechnology: Bolder BioTechnology awarded $593K to research radiation exposure
Dec 13, 2018
Business Wire
Press Release: Bolder BioTechnology : Ischemia Reperfusion Injury Pipeline Insight Report, 2018 - ResearchAndMarkets.com
Oct 24, 2018
PR Newswire
Press Release: Bolder BioTechnology : Bolder BioTechnology to Present Preclinical Data for Three Research Programs at Acute Radiation Syndrome Meeting
Sep 06, 2018
PR Newswire
Press Release: Bolder BioTechnology : Bolder BioTechnology Announces Presentation at Radiation Injury Treatment Conference
May 01, 2018
InnovationNews
Bolder BioTechnology: Bolder BioTechnology announces positive results for cancer treatment drug
Aug 02, 2017
BioSpace
Bolder BioTechnology: Bolder BioTechnology, Inc. Announces Initiation Of Phase I Clinical Trial Of BBT-015 For Treating Neutropenia And Acute Radiation Syndrome
Dec 10, 2016
BioPortfolio
Bolder BioTechnology: Bolder BioTechnology Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350
Apr 03, 2016
NewsMaker
Press Release: Bolder BioTechnology :
Chemotherapy Induced Neutropenia Therapeutics & Drugs Pipeline Review, H1 2016
Bolder BioTechnology Competitors
1
2
3
4
5
6
7
8
9
10